Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

oncology

  • You have access
    Signaling Pathways That Drive 18F-FDG Accumulation in Cancer
    Jessica R. Salas and Peter M. Clark
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 659-663; DOI: https://doi.org/10.2967/jnumed.121.262609
  • You have access
    PET/MRI Improves Management of Children with Cancer
    Lucia Baratto, K. Elizabeth Hawk, Lisa States, Jing Qi, Sergios Gatidis, Louise Kiru and Heike E. Daldrup-Link
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1334-1340; DOI: https://doi.org/10.2967/jnumed.120.259747
  • You have access
    Update on the Evaluation of Thyroid Nodules
    Victor J. Bernet and Ana-Maria Chindris
    Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.120.246025
  • You have access
    Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer
    Andrea Farolfi, Letizia Calderoni, Francesco Mattana, Riccardo Mei, Sivi Telo, Stefano Fanti and Paolo Castellucci
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 596-604; DOI: https://doi.org/10.2967/jnumed.120.257238
  • You have access
    FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
    Rodney J. Hicks, Peter J. Roselt, Kumarswamy G. Kallur, Richard W. Tothill and Linda Mileshkin
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 296-302; DOI: https://doi.org/10.2967/jnumed.120.256271
  • Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
    Open Access
    Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
    Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis and Freddy E. Escorcia
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 366-371; DOI: https://doi.org/10.2967/jnumed.120.244897
  • Synthesis of the PET Tracer <sup>124</sup>I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    You have access
    Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
    Edwin C. Pratt, Elizabeth Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty and Jan Grimm
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1845-1850; DOI: https://doi.org/10.2967/jnumed.120.241901
  • The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    You have access
    The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot and Marjolijn N. Lub-de Hooge
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1594-1601; DOI: https://doi.org/10.2967/jnumed.120.241877
  • You have access
    Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
    Susanne Lütje, Georg Feldmann, Markus Essler, Peter Brossart and Ralph A. Bundschuh
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1137-1144; DOI: https://doi.org/10.2967/jnumed.119.237891
  • You have access
    18F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome
    Anne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Jérôme Clerc, Franck Morschhauser, Olivier Casasnovas, Michel Meignan and Irène Buvat
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 40-45; DOI: https://doi.org/10.2967/jnumed.119.229450

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire